Alaunos Therapeutics Analyst Ratings
Alaunos Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/16/2023 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 08/15/2023 | — | Laidlaw & Co. | Downgrades | Buy → Hold | |
| 05/15/2023 | 979.14% | HC Wainwright & Co. | → $1.5 | Upgrades | Neutral → Buy |
| 03/27/2023 | 2058.27% | Wells Fargo | → $3 | Assumes | → Overweight |
| 10/04/2022 | 2058.27% | Wells Fargo | → $3 | Assumes | → Overweight |
| 07/15/2022 | 2058.27% | Cantor Fitzgerald | → $3 | Assumes | → Overweight |
| 05/04/2022 | 2058.27% | Wells Fargo | → $3 | Upgrades | Equal-Weight → Overweight |
| 日期 | 上行/下行 | 分析师事务所 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/16/2023 | — | HC Wainwright & Co. | 降级 | 买入 → 中性 | |
| 08/15/2023 | — | Laidlaw & Co. | 降级 | 买入 → 持有 | |
| 05/15/2023 | 979.14% | HC Wainwright & Co. | → 1.5 美元 | 升级 | 中性 → 买入 |
| 03/27/2023 | 2058.27% | 富国银行 | → 3 美元 | 假设 | → 超重 |
| 2022 年 4 月 10 日 | 2058.27% | 富国银行 | → 3 美元 | 假设 | → 超重 |
| 07/15/2022 | 2058.27% | 坎托·菲茨杰拉德 | → 3 美元 | 假设 | → 超重 |
| 05/04/2022 | 2058.27% | 富国银行 | → 3 美元 | 升级 | 重量相等 → 超重 |
What is the target price for Alaunos Therapeutics (TCRT)?
Alaunos Therapeutics（TCRT）的目标价格是多少？
The latest price target for Alaunos Therapeutics (NASDAQ: TCRT) was reported by HC Wainwright & Co. on August 16, 2023. The analyst firm set a price target for $0.00 expecting TCRT to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月16日公布了Alaunos Therapeutics（纳斯达克股票代码：TCRT）的最新目标股价。该分析公司将目标股价设定为0.00美元，预计TCRT将在12个月内降至0.00美元（可能下跌-100.00％）。去年有5家分析公司公布了评级。
What is the most recent analyst rating for Alaunos Therapeutics (TCRT)?
Alaunos Therapeutics（TCRT）的最新分析师评级是多少？
The latest analyst rating for Alaunos Therapeutics (NASDAQ: TCRT) was provided by HC Wainwright & Co., and Alaunos Therapeutics downgraded their neutral rating.
Alaunos Therapeutics（纳斯达克股票代码：TCRT）的最新分析师评级由HC Wainwright & Co. 提供，Alaunos Therapeutics下调了中性评级。
When is the next analyst rating going to be posted or updated for Alaunos Therapeutics (TCRT)?
Alaunos Therapeutics（TCRT）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alaunos Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alaunos Therapeutics was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Alaunos Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Alaunos Therapeutics的最后一次评级是在2023年8月16日发布的，因此您应该预计下一个评级将在2024年8月16日左右公布。
Is the Analyst Rating Alaunos Therapeutics (TCRT) correct?
分析师评级Alaunos Therapeutics（TCRT）是否正确？
While ratings are subjective and will change, the latest Alaunos Therapeutics (TCRT) rating was a downgraded with a price target of $0.00 to $0.00. The current price Alaunos Therapeutics (TCRT) is trading at is $0.14, which is out of the analyst's predicted range.
尽管评级是主观的，并将发生变化，但最新的Alaunos Therapeutics（TCRT）评级下调，目标股价为0.00美元至0.00美元。Alaunos Therapeutics（TCRT）目前的交易价格为0.14美元，超出了分析师的预测区间。